Sulfinpyrazone

Pyrazolone-type dmgs, such as phenylbutazone and sulfinpyrazone, ate metabolized in the Hver by microsomal enzymes, forming glucutonide metabohtes that ate easily excreted because of enhanced water solubility. [Pg.316]

Fig. 2. Pyrazole-derived pharmaceuticals (a) butaglyon [2603-23-8] an antidiabetic (b) dazopride [70181 -03-2] an antiemetic (c) feclobuzo [23111-34 ] an antiinflammatory (d) kebuzone [833-34-9], an antirheumatic (e) muzolimin [55294-15-0], a diuretic (f) phenazobz [20610-63-3], an antiasthmatic (g) selenofob [39102-63-1], an antibiotic (h) sulfamazo [65761-24-2], an antiseptic and (i) sulfinpyrazone [57-96-5], an antigout preparation (50).

The daily dose of sulfinpyrazone is 200-400 mg. The side effects of sulfinpyrazone are comparable with those of probenecid. A potential therapeutic advantage of sulfinpyrazone in patients with coronary heart disease and thromboembolic diseases is its inhibitory effect on platelet aggregation. [Pg.139]

Uricosuric dtugs increase the renal excretion of uric acid by inhibiting its renal reabsorption. Therapeutically used uricosuric dtugs are benzbromarone, probenecid and sulfinpyrazone. [Pg.1268]

In those with gout, the serum uric acid level is usually elevated. Sulfinpyrazone increases the excretion of uric acid by the kidneys, which lowers serum uric acid levels and consequently retards the deposit of urate crystals in the joints. Probenecid (Benemid) works in the same manner and may be given alone or with colchicine as combination therapy when there are frequent, recurrent attacks of gout. Probenecid also has been used to prolong the plasma levels of the penicillins and cephalosporins. [Pg.187]

The drugp used for gout are contraindicated in patients with known hypersensitivity. Probenecid is contraindicated in patients with blood dyscrasias or uric acid kidney stones and in children younger than 2 years. Sulfinpyrazone is contraindicated in patients with peptic ulcer disease and gastrointestinal inflammation. Colchicine is contraindicated in patients with serious gastrointestinal, renal, hepatic, or cardiac disorders and those with blood dyscrasias. [Pg.187]

Sulfinpyrazone may increase die anticoagulant activity of oral anticoagulants. There is an increased risk of hypoglycemia when sulfinpyrazone is administered with tolbutamide. Concurrent administration of sulfinpyrazone widi verapamil may decrease die effectiveness of verapamil. [Pg.191]

Chloral hydrate Chloramphenicol Cimetidine Ciprofloxacin Clofibrate Danazol Disulfiram Doxycycline Erythromycin Fenofibrate Fluconazole Fluorouracil Fluoxetine Fluvoxamine Gemfibrozil Influenza vaccine Isoniazid Itraconazole Fovastatin Metronidazole Miconazole Moxalactam Neomycin Norfloxacin Ofloxacin Omeprazole Phenylbutazone Piroxicam Propafenone Propoyxphene Quinidine Sertraline Sulfamethoxazole Sulfinpyrazone Tamoxifen Testosterone Vitamin E Zafirlukast... [Pg.153]

Other drugs that are commonly implicated in causing ARF include acyclovir, adefovir, carboplatin, cidofovir, cisplatin, foscarnet, ganciclovir, indinavir, methotrexate, pentamidine, ritonavir, sulfinpyrazone, and tenofovir.45... [Pg.371]

Sulfinpyrazone was used in the past but is no longer available in the United States. Several other medications have... [Pg.896]

Sulfoxide reductase Removal of oxygen from sulfoxide Sulfinpyrazone... [Pg.513]

Probenecid and sulfinpyrazone increase the renal clearance of uric acid by inhibiting the renal tubular reabsorption of uric acid. They should only be... [Pg.20]

The initial dose of sulfinpyrazone is 50 mg twice daily for 3 to 4 days, then 100 mg twice daily, increasing the daily dose by 100-mg increments each week up to 800 mg/day. [Pg.21]

Hydrocortisone hemisuccinate Ibuprofen Indomethacin Ketoprofen Mefenamic acid Naproxen Noramidopyrine Oxyphenbutazone Phenylbutazone Piroxicam Sulindac Sulfinpyrazone Tartrazine Tolmetin... [Pg.980]

See also in sourсe #XX -- [ Pg.238 ]

See also in sourсe #XX -- [ Pg.71 ]

See also in sourсe #XX -- [ Pg.316 ]

See also in sourсe #XX -- [ Pg.238 ]

See also in sourсe #XX -- [ Pg.40 , Pg.41 , Pg.329 ]

See also in sourсe #XX -- [ Pg.292 ]

See also in sourсe #XX -- [ Pg.367 , Pg.435 , Pg.659 , Pg.729 ]

See also in sourсe #XX -- [ Pg.1160 ]

See also in sourсe #XX -- [ Pg.84 , Pg.93 , Pg.94 ]

See also in sourсe #XX -- [ Pg.297 ]

See also in sourсe #XX -- [ Pg.215 ]

See also in sourсe #XX -- [ Pg.292 ]

See also in sourсe #XX -- [ Pg.3 , Pg.3 , Pg.50 , Pg.54 ]

See also in sourсe #XX -- [ Pg.1938 ]

See also in sourсe #XX -- [ Pg.417 , Pg.417 ]

See also in sourсe #XX -- [ Pg.264 ]

See also in sourсe #XX -- [ Pg.295 ]

See also in sourсe #XX -- [ Pg.3 , Pg.3 , Pg.139 , Pg.140 ]

See also in sourсe #XX -- [ Pg.870 ]

See also in sourсe #XX -- [ Pg.80 , Pg.82 , Pg.185 ]

See also in sourсe #XX -- [ Pg.302 ]

See also in sourсe #XX -- [ Pg.73 , Pg.77 ]

See also in sourсe #XX -- [ Pg.633 ]

See also in sourсe #XX -- [ Pg.125 ]

See also in sourсe #XX -- [ Pg.26 , Pg.41 , Pg.311 , Pg.631 , Pg.660 ]

See also in sourсe #XX -- [ Pg.327 , Pg.327 ]

See also in sourсe #XX -- [ Pg.293 , Pg.300 , Pg.542 ]

See also in sourсe #XX -- [ Pg.292 ]

See also in sourсe #XX -- [ Pg.136 ]

See also in sourсe #XX -- [ Pg.836 , Pg.837 , Pg.1000 , Pg.1000 ]

See also in sourсe #XX -- [ Pg.217 ]

See also in sourсe #XX -- [ Pg.10 , Pg.37 , Pg.420 ]

See also in sourсe #XX -- [ Pg.62 ]

See also in sourсe #XX -- [ Pg.78 ]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...